Virtu KCG Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Virtu KCG Holdings’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.34M	Buy	+26,386	New	+$1.23M	0.04%	414
2017 Q1	–	Sell	-32,130	Closed	-$1.54M	–	3433
2016 Q4	$1.54M	Buy	+32,130	New	+$1.27M	0.04%	453
2016 Q3	–	Sell	-10,826	Closed	-$252K	–	3260
2016 Q2	$252K	Sell	10,826 -2,690	-20%	-$86.8K	0.01%	2065
2016 Q1	$547K	Buy	+13,516	New	+$549K	0.02%	1107
2015 Q4	–	Sell	-44,629	Closed	-$1.8M	–	3702
2015 Q3	$1.8M	Sell	44,629 -14,707	-25%	-$761K	0.03%	504
2015 Q2	$3.42M	Buy	59,336 +44,171	+291%	+$2.81M	0.06%	236
2015 Q1	$966K	Sell	15,165 -2,249	-13%	-$153K	0.02%	806
2014 Q4	$1.07M	Buy	17,414 +10,212	+142%	+$504K	0.02%	864
2014 Q3	$280K	Buy	+7,202	New	+$255K	0.01%	2454
2013 Q4	–	Sell	-14,415	Closed	-$541K	–	4001
2013 Q3	$541K	Buy	+14,415	New	+$431K	0.01%	1910

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Virtu KCG Holdings's IONS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2017: 26,386 shares worth $1.34M. The stake represents 0.04% of the portfolio and ranks #414 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in IONS as recently as Q4 2016.

Virtu KCG Holdings first reported a position in IONS in Q3 2013 and has held it in 10 quarters since. The position peaked at $3.42M in Q2 2015. 293 funds tracked by Wall St. Rank hold IONS as of Q2 2017.

Virtu KCG Holdings held 26,386 shares of Ionis Pharmaceuticals worth $1.34M as of Q2 2017.
Ionis Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
Ionis Pharmaceuticals made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #414 holding.
Virtu KCG Holdings first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 10 quarters since.
Virtu KCG Holdings's Ionis Pharmaceuticals position peaked at $3.42M in Q2 2015.
293 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.